Aponos - 10 Second Closure - Closing the Gap in Tissue Repair

Aponos Medical Corp has developed a breakthrough surgical tissue management technology platform designed to enable and facilitate complex surgical procedures using minimally invasive approaches. This technology has an estimated $300M in global growth potential and is focused on the rapidly evolving MIS (minimally invasive surgery) arena.
[CLICK] The Slide Show to see a Product Demo

Baystate Medical Center Padlock-G® Performance Studies
Tufts University School of Medicine, Springfield MA

• Padlock-G® Explant Pressure Study
• Padlock-G® Porcine 6 Week Survival Study

The Aponos technology consists of a single patient use device that provides the surgeon/endoscopist with several extremely powerful treatment options for their patients. This system platform combines a tissue management and closure device, [Padlock-G®], with a precise positioning/delivery system, [Lock-It®] to provide an endoscopically controlled and delivered tissue management means, not yet seen in competitive commercialized devices, to safely, quickly and effectively manage tissue in several ways, including:

• Providing a means to close tissue defects such as holes, perforations, fistulas, etc
• Providing a method to attach materials and/or anchor other theraputic devices to tissue.
• Providing a method of gathering tissue, raising it up from the surface, and locking it there, making it easily available for tissue manipulation while still providing a clear target that can be easily found many times if needed. A typical example is the removal of submucosal tumors.

Dr. J. R. Armengol-Miró Padlock-G® Clinical Use Demonstrations
World Institute for Digestive Endoscopy Research, Barcelona Spain

• Padlock-G® Esophageal Closure Sequence
• Padlock-G® Colon Closure Sequence

Procedures are accomplished remotely using state of the art minimally invasive surgical (“MIS”) techniques commonly used today, complimented by the unique adaptability of the Aponos Technology to fit the wide range and styles of existing off the shelf endoscopic devices.

• The Padlock-G® closure device and Lock-It® delivery system are not FDA approved for Human Use.
• We are actively seeking investigational use and procedure development partners.
• Please contact us with your research project needs.

Contact:

Ken A.Spector - CEO - 508-951-3133 - Click Here for Investor Information

Frank Patterson - VP - 603-770-9794 - Click Here for Research Materials